Teresa Paíno

7PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular medicineGene and molecular therapyMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 14, 2024
Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation.

Pablo Juanes-Velasco, Carlota Arias-Hidalgo, Marina L García-Vaquero

|May 11, 2024
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands.

Andrea Díaz-Tejedor, Javier Rodríguez-Ubreva, Laura Ciudad

|Apr 03, 2021
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma.

Esperanza M Algarín, Dalia Quwaider, Francisco J Campos-Laborie

|Apr 03, 2021
Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression.

Andrea Díaz-Tejedor, Mauro Lorenzo-Mohamed, Noemí Puig

|Dec 08, 2020
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.

Noemí Puig, Luis A Corchete-Sánchez, José J Pérez-Morán

|Sep 29, 2020
Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma.

Teresa Paíno, Lorena González-Méndez, Laura San-Segundo

Pageof 2

Frequent Collaborators

5 joint publications

Mercedes Garayoa

5 joint publications

Enrique M Ocio

4 joint publications

Andrea Díaz-Tejedor

3 joint publications

Pedro Mogollón